Video
Dr. Zorn discusses 3-year data on Aquablation
Author(s):
“I think Aquablation is safe. It’s efficacious, especially in these large prostates,” says Kevin Zorn, MD, FRCSC, FACS.
Video Player is loading.
In this video, Kevin Zorn, MD, FRCSC, FACS, discusses the findings and takeaways of the study, “Aquablation for benign prostatic hyperplasia in large prostates (80-150CC): 3-year results,” which was presented during the 2021 American Urological Association annual meeting. Zorn is an associate professor of urology at the University of Montreal, Canada.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
Andrea Pezzella, MD, URPS, FACOG, discusses Neuspera’s SNM device
Ashley Winter, MD, calls for label update on low-dose vaginal estrogen
Joseph Song, MD, on the emergence of new suction-based devices for stone disease
How eating disorders affect bladder and pelvic floor health
Sarah Razavi, MD, outlines strategies for mitigate surgeon discomfort during URS
Can ctDNA detect molecular residual disease in NMIBC?
Expert discusses setting realistic expectations for Rezum for BPH
Nicolette G. Payne, MD, discusses risk factors for burnout among pediatric urologists
Sacral neuromodulation device empowers patients with greater UUI control
Howard Goldman, MD, on his experience with the Glean Urodynamics System
Related Content
